European Commission authorises second safe and effective vaccine against COVID-19

Published on January 5, 2021

European Commission Press release Brussels, 06 Jan 2021 Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Moderna, the second COVID-19 vaccine authorised in the EU.

Other news

ECHO Daily Map of 05 Juanuary 2021

January 5, 2021
Arrivals of refugees and migrants to Europe in 2020

Sensing module keeps watch beneath the waves

January 6, 2021
EU-funded researchers have designed a standard instrument module to monitor conditions in the deep sea. As part of a Europe-wide marine-sensing infrastructure, the modules will supply reliable long-term data on the state of our seas and oceans.